The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics
Abstract
Marijuana is a currently illegal psychoactive drug that many physicians believe has substantial therapeutic uses. The medical literature contains a growing number of studies on cannabinoids as well as case studies and anecdotal reports suggesting therapeutic potential. Fifteen states have passed medical marijuana laws, but little is known about the growing population of patients who use marijuana medicinally. This article reports on a sample of 1,746 patients from a network of nine medical marijuana evaluation clinics in California. Patients completed a standardized medical history form; evaluating physicians completed standardized evaluation forms. From this data we describe patient characteristics, self-reported presenting symptoms, physician evaluations, other treatments tried, other drug use, and medical marijuana use practices. Pain, insomnia, and anxiety were the most common conditions for which evaluating physicians recommended medical marijuana. Shifts in the medical marijuana patient population over time, the need for further research, and the issue of diversion are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Expenditures and health status among adults with back and neck problems
Martin, B. I. (2008) · JAMA · doi:10.1001/jama.299.6.656 · Cited by 1,531 · cited 2×
“3% increase in the prevalence of spine problems between 1997 and 2005 (Martin et al. 2008).”
InfluentialResults From the 2008 National Survey on Drug Use and Health: National Findings: (592592009-001)
(2009) · PsycEXTRA Dataset · doi:10.1037/e592592009-001 · Cited by 1,176
Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency Departments
Pletcher, M. J., Kertesz, S. G., Kohn, M. A., & Gonzales, R. (2008) · JAMA · doi:10.1001/jama.2007.64 · Cited by 827
McSherry, B., & Duke, J. (1999) · Cited by 743
Crack in America: Demon Drugs and Social Justice
Covington, J., Reinarman, C., & Levine, H. (1998) · Contemporary Sociology · doi:10.2307/2655222 · Cited by 541
Self-citationBrecher, E. M. (1972) · Cited by 526
Price, E. (1980) · Cited by 302
Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential
(2003) · Choice Reviews Online · doi:10.5860/choice.40-3432 · Cited by 293
Hashibe, M., Morgenstern, H., Cui, Y., Tashkin, D. P., Zhang, Z.-F., Cozen, W., Mack, T. M., & Greenland, S. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0330 · Cited by 256
Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?
Gross, C. P., Smith, B. D., Wolf, E., & Andersen, M. (2008) · Cancer · doi:10.1002/cncr.23228 · Cited by 246
The medicinal use of cannabis in the UK: results of a nationwide survey
Ware, M. A., Adams, H., & Guy, G. W. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00271.x · Cited by 239
Abrams, D. I., Hilton, J. F., Leiser, R. J., Shade, S. B., Elbeik, T. A., Aweeka, F. T., Benowitz, N. L., Bredt, B. M., Kosel, B., Aberg, J. A., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-4-200308190-00008 · Cited by 238 · cited 8×
“African-Americans may be more likely to seek MM for any of several reasons: because they are disproportionately poor, more often lack health insurance, are significantly less likely to be prescribed other medication for pain (Pletcher et al. 2008) or to receive treatment for cancer (Gross et al. 2008), and because Afr…”
BackgroundInfluentialGrinspoon, L. (1969) · Scientific American · doi:10.1038/scientificamerican1269-17 · Cited by 209
Cannabis use in HIV for pain and other medical symptoms
Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.07.011 · Cited by 208 · cited 7×
“African-Americans may be more likely to seek MM for any of several reasons: because they are disproportionately poor, more often lack health insurance, are significantly less likely to be prescribed other medication for pain (Pletcher et al. 2008) or to receive treatment for cancer (Gross et al. 2008), and because Afr…”
InfluentialResults from the 2005 National Survey on Drug Use and Health: National Findings: (538292006-001)
(2006) · PsycEXTRA Dataset · doi:10.1037/e538292006-001 · Cited by 202
Marijuana and chronic obstructive lung disease: a population-based study
Tan, W. C., Lo, C., Jong, A., Xing, L., FitzGerald, M. J., Vollmer, W. M., Buist, S. A., Sin, D. D., & for the Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081040 · Cited by 201
Listening to Prozac - A psychiatrist explores antidepressant drugs and the remaking of the self
Krämer, P. (1994) · DigitalGeorgetown (Georgetown University Library) · Cited by 171
Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes.
Doblin, R., & Kleiman, M. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1314 · Cited by 108
Lehmann, A., Blackshaw, L. A., Brändén, L., Carlsson, A., Jensen, J. M., Nygren, E., & Smid, S. D. (2002) · Gastroenterology · doi:10.1053/gast.2002.36025 · Cited by 103
O'connell, T., & Bou-Matar, C. B. (2007) · Harm Reduction Journal · doi:10.1186/1477-7517-4-16 · Cited by 91
Medical Cannabis Patients: Patient Profiles and Health Care Utilization Patterns
Reiman, A. (2007) · Complementary health practice review · doi:10.1177/1533210107301834 · Cited by 74
Dewey, W. L., & Harris, L. S. (2003) · NIDA research monograph · Cited by 72
Barnes, J. (1998) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.1998.tb00785.x · Cited by 71
Ashton, C. H., Holdcroft, A., de Mars, S., Moffat, A. C., Pertwee, R. G., & Wall, P. D. (1997) · Cited by 69
Marijuana: The Forbidden Medicine
Beresford, T. P. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71873-3 · Cited by 67
Nicoll, R. A., & Alger, B. E. (2004) · Scientific American · doi:10.1038/scientificamerican1204-68 · Cited by 53
Reiman, A. (2007) · Health & Social Care in the Community · doi:10.1111/j.1365-2524.2007.00722.x · Cited by 25
Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self
E.B.B. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199406000-00017 · Cited by 3
Cited by
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
The Pharmacologic and Clinical Effects of Medical Cannabis
Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1187 · Cited by 423
Evaluating the public health impacts of legalizing recreational cannabis use in the United States
Hall, W., & Lynskey, M. (2016) · Addiction · doi:10.1111/add.13428 · Cited by 357
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
Walsh, Z., Callaway, R., Belle-Isle, L., Capler, R., Kay, R., Lucas, P., & Holtzman, S. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.08.010 · Cited by 347
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
Bradford, A. C., & Bradford, W. D. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1661 · Cited by 341
Metadata
- Authors
- Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T.
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 43
- Issue
- 2
- Pages
- 128-135
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W2027897070
- Cited by
- 290
- References
- 29
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.